<DOC>
	<DOCNO>NCT00360009</DOCNO>
	<brief_summary>The purpose trial study mood cognitive effect deep brain stimulation Parkinson 's disease .</brief_summary>
	<brief_title>Effects Deep Brain Stimulation Motor , Mood , Cognitive Symptoms Parkinson 's Disease</brief_title>
	<detailed_description>Deep brain stimulation ( DBS ) subthalamic nucleus ( STN ) globus pallidus interna ( GPi ) show relieve motor symptom Parkinson 's disease ( PD ) tremor , rigidity , bradykinesia . However , increase evidence DBS may associate significant number mood cognitive change . The aim study characterize compare mood cognitive effect associate DBS STN GPi , delineate region within around STN GPi associate specific mood cognitive change DBS apply area , assess relative effectiveness right versus leave STN GPi stimulation mood cognition . In study , researcher compare motor , mood , cognitive function people PD DBS treatment control subject ( individual PD DBS ) . The scientist characterize type incidence mood cognitive change occur DBS target ( STN GPi ) , compare target , examine role lead location . The study enroll 62 participantsâ€”10 control subject ( individual PD DBS ) , 52 individual PD schedule DBS ; site implant ( STN GPi ) randomly assign . Participants perform motor , mood , cognitive test ( follow 6 month stimulation ) 2-day period . Duration trial participant 6 month include 2-night hospital stay . Findings study may help researcher well understand DBS affect non-motor circuitry .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Intractable , disable PD motor fluctuation , dyskinesia , freeze episode Age 3075 year Unsatisfactory clinical response maximal medical management ( trial high low dos antiParkinsonian drug ) A stable optimal medical regimen antiParkinsonian drug therapy least three month prior surgery Patients must righthanded include study since mood cognition analyze right hemisphere dominant patient could confound result . Clinically significant medical disease would increase risk develop pre postoperative complication ( e.g. , significant cardiac pulmonary disease , uncontrolled hypertension ) Evidence secondary atypical parkinsonism suggest presence following : 1 ) history stroke ( ) , 2 ) exposure toxins neuroleptic , 3 ) history encephalitis , 4 ) neurological sign upper motor neuron disease , cerebellar involvement , supranuclear gaze palsy , significant orthostatic hypotension MRI scan significant evidence brain atrophy abnormality ( e.g. , lacunar infarct iron deposit putamen ) The Mattis Dementia Rating Scale use assess level intellectual function patient exclude score reflect clinical dementia A major psychiatric disorder Structured Clinical Interview DSMIV ( SCIDIV ) .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Parkinson disease</keyword>
	<keyword>PD</keyword>
	<keyword>deep brain stimulation</keyword>
	<keyword>DBS</keyword>
	<keyword>subthalamic nucleus</keyword>
	<keyword>STN</keyword>
	<keyword>globus pallidus interna</keyword>
	<keyword>GPi</keyword>
	<keyword>mood</keyword>
	<keyword>motor symptom</keyword>
	<keyword>cognition</keyword>
	<keyword>emotion</keyword>
	<keyword>memory</keyword>
	<keyword>attention</keyword>
	<keyword>tremor</keyword>
	<keyword>rigidity</keyword>
	<keyword>bradykinesia</keyword>
</DOC>